INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif., October 09, 2024--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to ...
For years, there have been bottlenecks in the medicine supply in Europe. These have worsened in recent months in Germany. Analysts say that respite is unlikely to come any time soon.
id=241160711 The prominent players of global Cattle & porcine/swine reproductive diseases market are Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmBH (Germany ...
An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
Learn more at https://www.boehringer-ingelheim.com. This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.
Learn more at https://www.boehringer-ingelheim.com. This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.
GSK has always refuted claims that its discontinued heartburn drug had cancer-causing risks, arguing that expert testimonies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback